Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Roschewski Website

Mark J. Roschewski, M.D.

Selected Publications

1)  Roschewski M, Korde N, Wu SP, Landgren O.
Pursuing the curative blueprint for early myeloma.
Blood. 122: 486-90, 2013.
[Journal]
2)  Roschewski M, Farooqui M, Aue G, Wilhelm F, Wiestner A.
Phase I study of ON 01910.Na (Rigosertib), a multikinase PI3K inhibitor in relapsed/refractory B-cell malignancies.
Leukemia. 27: 1920-3, 2013.
[Journal]
3)  Roschewski M, Dunleavy K, Wilson WH.
Diffuse large B cell lymphoma: molecular targeted therapy.
Int. J. Hematol. 96: 552-61, 2012.
[Journal]
4)  Roschewski M, Wilson WH.
Biology and management of rare primary extranodal T-cell lymphomas.
Oncology (Williston Park, N.Y.). 24: 94-100, 2010.
[Journal]
5)  Roschewski M, Wilson WH.
EBV-associated lymphomas in adults.
Best Pract Res Clin Haematol. 25: 75-89, 2012.
[Journal]
6)  Roschewski M, Wilson WH.
Lymphomatoid granulomatosis.
Cancer J. 18: 469-74, 2012.
[Journal]
7)  Chapman CM, Sun X, Roschewski M, Aue G, Farooqui M, Stennett L, Gibellini F, Arthur D, Pérez-Galán P, Wiestner A.
ON 01910.Na is selectively cytotoxic for chronic lymphocytic leukemia cells through a dual mechanism of action involving PI3K/AKT inhibition and induction of oxidative stress.
Clin. Cancer Res. 18: 1979-91, 2012.
[Journal]
8)  Cherry BM, Korde N, Kwok M, Roschewski M, Landgren O.
Evolving therapeutic paradigms for multiple myeloma: back to the future.
Leuk. Lymphoma. 54: 451-63, 2013.
[Journal]
9)  Cherry BM, Korde N, Kwok M, Manasanch EE, Bhutani M, Mulquin M, Zuchlinski D, Yancey MA, Maric I, Calvo KR, Braylan R, Stetler-Stevenson M, Yuan C, Tembhare P, Zingone A, Costello R, Roschewski MJ, Landgren O.
Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical study.
Leuk. Lymphoma. [Epub ahead of print], 2013.
[Journal]
10)  Davidson-Moncada JK, McDuffee E, Roschewski M.
CD5+ diffuse large B-cell lymphoma with hemophagocytosis.
J. Clin. Oncol. 31: e76-9, 2013.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 4/11/2014.